CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Cancer Stem Cell for Tumor Therapy.
Cancer Stem Cell for Tumor Therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤严重威胁人类健康。尽管手术、化疗和放疗等多种方法旨在清除肿瘤细胞,治疗效果仍不理想。靶向治疗因具有特异性和高效性而显示出潜力。同时,研究已发现癌症干细胞(CSC)在肿瘤发生、发展、转移和复发中发挥关键作用。因此,靶向CSC抑制肿瘤有望改善预后。本综述系统阐述CSC的生物学特征,包括有丝分裂模式、代谢表型、治疗耐药性及相关机制。最后总结靶向CSC的策略,包括靶向CSC表面标志物、相关信号通路、CSC生态位和代谢通路,诱导分化治疗,以及免疫疗法(肿瘤疫苗、CAR-T、溶瘤病毒、靶向CSC与免疫细胞相互作用和免疫检查点抑制剂)。本文重点介绍免疫治疗及其与不同作用机制药物联合开展抗CSC治疗的潜力。
Tumors pose a significant threat to human health. Although many methods, such as operations, chemotherapy and radiotherapy, have been proposed to eliminate tumor cells, the results are unsatisfactory. Targeting therapy has shown potential due to its specificity and efficiency. Meanwhile, it has been revealed that cancer stem cells (CSCs) play a crucial role in the genesis, development, metastasis and recurrence of tumors.
Thus, it is feasible to inhibit tumors and improve prognosis via targeting CSCs. In this review, we provide a comprehensive understanding of the biological characteristics of CSCs, including mitotic pattern, metabolic phenotype, therapeutic resistance and related mechanisms.
Finally, we summarize CSCs targeted strategies, including targeting CSCs surface markers, targeting CSCs related signal pathways, targeting CSC niches, targeting CSC metabolic pathways, inducing differentiation therapy and immunotherapy (tumor vaccine, CAR-T, oncolytic virus, targeting CSCs-immune cell crosstalk and immunity checkpoint inhibitor).
We highlight the potential of immunity therapy and its combinational anti-CSC therapies, which are composed of different drugs working in different mechanisms.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。